Detalles de la búsqueda
1.
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.
Clin Infect Dis
; 78(3): 756-764, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340060
2.
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis.
Antimicrob Agents Chemother
; 68(1): e0079423, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112526
3.
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.
Antimicrob Agents Chemother
; 67(12): e0061123, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971239
4.
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.
Antimicrob Agents Chemother
; 67(7): e0144822, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358463
5.
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children.
J Antimicrob Chemother
; 78(10): 2481-2488, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596982
6.
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children.
Clin Infect Dis
; 74(8): 1372-1381, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34286843
7.
Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant Tuberculosis.
Clin Infect Dis
; 75(10): 1772-1780, 2022 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377434
8.
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
Clin Infect Dis
; 75(1): 141-151, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34665866
9.
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial.
Antimicrob Agents Chemother
; 66(5): e0214421, 2022 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35404075
10.
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 66(6): e0226421, 2022 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35506699
11.
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial.
J Antimicrob Chemother
; 76(12): 3237-3246, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34529779
12.
Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30104267
13.
Erratum for van der Laan et al., "Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis".
Antimicrob Agents Chemother
; 67(7): e0072023, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338349
14.
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133558
15.
Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.
Sex Transm Infect
; 94(1): 55-61, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28490581
16.
Emerging data on rifampicin pharmacokinetics and approaches to optimal dosing in children with tuberculosis.
Expert Rev Clin Pharmacol
; 15(2): 161-174, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285351
17.
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis.
Front Pharmacol
; 12: 722204, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34690765
18.
HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL.
Papillomavirus Res
; 3: 50-56, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28480334
19.
Adverse effects of oral second-line antituberculosis drugs in children.
Expert Opin Drug Saf
; 15(10): 1369-81, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27458876
20.
Probable Levofloxacin-associated Secondary Intracranial Hypertension in a Child With Multidrug-resistant Tuberculosis.
Pediatr Infect Dis J
; 35(6): 706-8, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26974890